There is no more exciting time to be a part of cancer medicine than now. The benefits of our pioneering discoveries are making a difference where it matters most—in the lives of patients.
This is the time of translational and individualized cancer medicine—discoveries that transcend the boundaries of the laboratory bench to make a difference at the bedsides of our patients and families. The Johns Hopkins Kimmel Cancer Center is a leader in translational cancer medicine because of private gifts that have provided us with the resources to move our discoveries from the laboratory to cancer patients.
As we develop these new therapies that specifically target cancer cells, we are seeing unheard-of responses—aggressive and advanced cancers are being thwarted, cancers unchanged by multiple assaults by standard therapy are now being held in check. We now have the technology to apply what we’ve learned to each patient’s unique cancer. The convergence of this technology with brilliant scientific minds and the impact of philanthropy has brought us to a point now where we can begin to alter the course of cancer in ways we could only imagine just a few decades ago.
At the Kimmel Cancer Center, we are truly on the precipice of something great. Your gift assures that we continue this important work. Thank you.
Discover some of the ways our centers and divisions are innovating to change lives. In our C-Answers video series, faculty and staff of the Johns Hopkins Kimmel Cancer Center answer your questions about cancer.
|C-Answers - Diet, Nutrition and Cancer|
Bill Nelson discusses how the foods you eat and the way you cook them can impact cancer. Diet and Nutrition tips about cancer.
|C-Answers - Mapping Cancer's Secrets|
Bert Vogelstein discusses how scientists are mapping the secrets within cancer genomes.
|C-Answers - Putting the Punctuation on Cancer|
Stephen Baylin describes how tiny "epigenetic" marks act as punctuation on DNA, deciding how it's read.
|C-Answers - Transplants for cancer|
Rick Jones discusses bone marrow transplants for cancers like leukemia, lymphoma and non-cancerous diseases like sickle cell anemia and aplastic anemia. He also talks about haplo-identical transplants using brothers and sisters of patients as marrow donors.